FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule
Dockets Management


C 35
Volume 149


Advisory Committee on Immunization Practices. Use of anthrax vaccine in the United States. MMWR-Morbidity & Mortality Weekly Report 2000; 49 (RR-15): 1-20, http://www.cdc.gov/mmwr/PDF/rr/rr4915.pdf, part 2, part 3

Advisory Committee on Immunization Practices. General recommendations on immunization. MMWR-Morbidity & Mortality Weekly Report 2002; 51 (RR-2): 1-35. www.cdc.gov/mmwr/PDF/rr/rr5102.pdf, part 2

Brachman, P et al. Field Evaluation of a Human Anthrax Vaccine. American Journal of Public Health, volume 52, No. 4, April, 1962, pages 632-45. Published Material

Advisory Committee on Immunization Practices. Recommended childhood and adolescent immunization schedule - United States, 2005. MMWR-Morbidity & Mortality Weekly Report 2005: 53 (51); Ql-Q3, January 7, 2005, http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5351-Immunizationa1.htm

Atkinson WL, Pickering LK, Watson JC, Peter G. General immunization practices, In: Plotkin SA, Orenstein WA, ed. Vaccines, 4th ed, Philadelphia: Elsevier, 2003: 91-122. Published Material

Centers for Disease Control and Prevention. Limited supply of pneumococcal conjugate vaccine: Suspension of recommendation for fourth dose. MMWR-Morbidity & Motiahy Weekly Report 2004: 53 (05) 108-109; http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5305a6.htm

Centers for Disease Control & Prevention. Interim influenza vaccination recommendations, 2004-05 influenza season. MMWR-Morbidity & Mortality Weekly Report 2004; 53: 923-5. http://www.cdc.gov/mmwr/PDF/wk/mm5339.pdf

Centers for Disease Control & Prevention, 2005, http://www.cdc.gov/nip/recs/child-schedule.htm#catchup

Food and Drug Administration, Final Rule, 61 Federal Register 40153 (August 1, 1996).

General Accounting Office: GAO-02-987, "Childhood Vaccines: Ensuring an Adequate Supply Poses Continuing Challenges." September 2002. http://www.gao.gov/new.items/d02987.pdf

Hadler SC, de Monzon MA, Lugo DR, Perez M. Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians. Vaccine 1989; 7: 106-10. Published Material

Jilg W, Schmidt M, Deinhardt F. Immune responses to late booster doses of hepatitis B vaccine. Journal of Medical Virology 1985; 17: 249-54. Published Material

Marsano LS, West DJ, Chan I, Hesley TM, Cox J, Hackworth V, Greenberg RN. A two-dose hepatitis B vaccine regimen: Proof of priming and memory responses in young adults. Vaccine 1998; 16: 624-9. Published Material

McBean AM, Thorns ML, Albrecht P, et al. Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. American Journal of Epidemiology 1988; 128: 615-28. Published Material

Pickering LK, ed. 2003 Red Book: Report of the Committee on Infectious Diseases, 26th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2003: 33. Published Material

Pittman PR, Hack D, Mangiafico J, Gibbs P, McKee KT Jr., Eitzen EM, Friedlander AM, Sjogren MH. Antibody response to a delayed booster dose of anthrax vaccine and botulinum toxoid. Vaccine 2002; 20 (May 15): 2107-15. Published Material

Pittman PR, Kim-Ahn G, Pifat DY, Coonan K, Gibbs P, Little Si Pace-Templeton JG, Myers R, Parker GW, Friedlander AM. Anthrax vaccine: Safety and iinmunogenicity of a dose-reduction, route comparison study in humans. Vaccine 2002; 20 (Jan 31): 1412-20. http://www.vaccines.mil/documents/library/Immunogenicity.pdf Published Material

Pittman PR, Mangiafico JA, Rossi CA, Cannon TL, Gibbs PH, Parker GW, Friedlander AM. Anthrax vaccine: Increasing intervals between the first two doses enhances antibody response in humans. Vaccine 2000; 18: 213-216. www.vaccines.mil/documents/library/Antibody_resp.pdf Published Material

Salk J. One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine. Review of Infectious Diseases 1984; 6 (suppl2): S444-50. Published Material

Wistrom J, Ahlm C, Lundberg S, Settergren B, Tamvik A. Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine 1999; 17: 2162-5. Published Material

Top | Back

Page last updated July 27, 2005 RSChorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management